Updated
Reviewed
Dec. 29, 2020
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Table 10. Antiretroviral Drug Use in Pregnant Women with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy
Note: When using FDCs, refer to other sections in Appendix B and Table 10 for information about the dosing and safety of individual drug components of the FDC during pregnancy.
Table 10. Antiretroviral Drug Use in Pregnant Women with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | |
---|---|
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Table 10. Antiretroviral Drug Use in Pregnant Women with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy
Note: When using FDCs, refer to other sections in Appendix B and Table 10 for information about the dosing and safety of individual drug components of the FDC during pregnancy.
Table 10. Antiretroviral Drug Use in Pregnant Women with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | |
---|---|
Download Guidelines
- Section OnlyPDF (950.89 KB)
- Full GuidelinePDF (5.11 MB)
- Recommendations OnlyPDF (878.67 KB)
- Tables OnlyPDF (1.86 MB)